Evidence map›Paper›PMID 36286451›Full record

ArticleMarine drugs2022

Therapeutic Potential of Microalgae-Derived Bioactive Metabolites Is Influenced by Different Large-Scale Culture Strategies.

Jezabel Garcia-Parra, Claudio Fuentes-Grünewald, Deyarina Gonzalez

Abstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jezabel Garcia-ParraFaculty of Medicine, Health and Life Science, Swansea University, Singleton Park, Swansea SA2 8PP, UK.ORCID 0000-0002-4235-4427
Claudio Fuentes-GrünewaldFaculty of Science and Engineering, Swansea University, Singleton Park, Swansea SA2 8PP, UK.
Deyarina GonzalezFaculty of Medicine, Health and Life Science, Swansea University, Singleton Park, Swansea SA2 8PP, UK.ORCID 0000-0002-1838-6752

Funding

Interreg Atlantic Area European Regional development fund Enhance Microalgae EAPA_338/2016Ministry of Environment, Water and Agriculture (MEWA) of the Kingdom of Saudi Arabia project number: 52000003916Swansea University Medical School departmental funds N/A
6 · The paper itself

Abstract

Microalgae have been identified as one of the most promising sources of novel bioactive compounds for biomedical applications, the food industry, and cosmetics. In the last decade, several biotechnological developments have facilitated the identification of a growing number of compounds as well as the study of optimal microalgae culture conditions for the production of biomass enriched in specific molecules of interest. In this study, two common commercial marine microalgae (

Indexed as

MicroalgaePorphyridiumAntioxidantsBiomassPlant ExtractsAntioxidantsPlant Extractsantitumourbiomassbiotechnologycancer cellsmicroalgaetherapeutic

Identifiers

PMID36286451
PMCPMC9605503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.